Fluvoxamine and Edoxaban: Interaction Details
- Fluvoxamine
- LuvoxLuvox CR
- Edoxaban
- Savaysa
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Fluvoxamine and Edoxaban interaction:
Fluvoxamine
- Luvox
- Luvox CR
What Happens When You Take Fluvoxamine With Edoxaban
What can happen when they are taken together (rated Major)
An increased risk of bleeding
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
release , and this release contributes to the maintenance of hemostasis. Case-control and cohort studies have linked of and with a higher risk of bleeding.125
The reported bleeding events ranged from epistaxis, ecchymosis, hematoma, and petechiae to life-threatening hemorrhages. Changes in anticoagulant effect, including more bleeding, have been described when SSRIs are given together with warfarin.
When patients took warfarin and fluvoxaMINE together for 2 weeks, plasma warfarin concentrations rose by 98% and prothrombin times were prolonged. FluvoxaMINE seems to inhibit multiple isoenzymes, possibly including and , which are the isozymes responsible for metabolizing warfarin.35
The Fluvoxamine and Edoxaban Interaction, Explained
Taking fluvoxamine with edoxaban can raise your chance of bleeding. Edoxaban is a that helps prevent clots. Fluvoxamine, used for OCD and sometimes depression, affects , the cells that help blood clot. Together, these two effects add up. You might notice nosebleeds, easy bruising, tiny red spots on the skin, or, less often, more serious bleeding.
Many people take both safely. Do not change or stop either medicine on your own. Tell your pharmacist or doctor about any unusual bleeding or bruising, and ask whether you need closer monitoring.
impairment of hemostasis (). deplete and impair platelet aggregation, which adds to factor Xa by edoxaban. Observational data (case-control and cohort) with SSRIs and show increased bleeding risk, including epistaxis, ecchymosis, hematoma, and major . Evidence is rated probable; onset is delayed.
- The documented fluvoxamine / inhibition (warfarin concentrations rose 98%) is specific to warfarin and is not established for edoxaban.
- Management: monitor for signs of bleeding, reassess periodically, and adjust the anticoagulant dose as clinically indicated. Routine is not informative for edoxaban.
See the 5 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Fluvoxamine and Edoxaban Interact
The likely mechanism
effects on hemostasis
How to Manage the Fluvoxamine and Edoxaban Interaction
Your care team can manage this combination with monitoring and individualized dosing.
- Keep taking both medicines exactly as prescribed unless your prescriber tells you otherwise.
- Expect your team to watch for signs of bleeding. Your dose may need to be adjusted and individualized by your care team.
- Report nosebleeds, unusual bruising, tiny red spots on the skin, blood in urine or stool, or any severe or lasting bleeding.
- Let your pharmacist or prescriber know before starting or stopping fluvoxamine or any other medicine that affects bleeding.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Fluvoxamine or Edoxaban need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
4 reports from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Risk of clinically relevant bleeding in warfarin-treated patients-influence of SSRI treatment
A retrospective cohort study (n=234) found an elevated risk of clinically relevant bleeding (defined as hospital admission due to bleeding) among patients taking warfarin for atrial fibrillation who were receiving an concomitantly or who had stopped an SSRI within the previous 2 weeks. Patients with a mean age of 72 +/- 7 years who received warfarin plus an SSRI (n=117) were matched with randomly selected patients who received warfarin alone (n=117).
The included FLUoxetine, citalopram, PARoxetine, sertraline, fluvoxaMINE, or escitalopram. In the warfarin plus SSRI group, 9 patients had 11 bleeding episodes over 213.9 treatment years, while in the warfarin-only group, 10 patients had 14 bleeding episodes over 586.4 treatment years.
The respective total bleeding incidences were 51.4 and 23.9 per 1000 treatment years. Compared with warfarin alone, the hazard ratio for first bleeding episodes during warfarin plus SSRI treatment was 3.49 (95% CI; 1.37 to 8.91, p=0.009).
The SSRIs involved in patients who bled during were sertraline or citalopram. Adding an SSRI was not linked to any change in warfarin dose or (p=0.48 and p=0.31, respectively). The study findings may be limited by prior bleeding events, unknown patient adherence, and the exclusion from the model of clopidogrel, dipyridamol, , and other than warfarin.2
-
Report 2 · Study title
Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins
A population-based, case-controlled study of new coumarin users (acenocoumarol and phenprocoumon) taking selective reuptake () found a higher risk of hospitalization for non-gastrointestinal bleeding. Using national pharmacy and hospitalization records, researchers in the Netherlands identified 1848 cases admitted for abnormal bleeding and compared them with 5818 control subjects who were also taking coumarins.
The median treatment duration in patients was 220 days (range, 1 to 4690 days). Patients taking SSRIs had a greater risk of hospitalization for non-gastrointestinal bleeding (adjusted odds ratio (OR) 1.7, 95% confidence interval (CI), 1.1 to 2.5), whereas the rate of bleeding (adjusted OR 0.8, 95% CI, 0.4 to 1.5) did not differ significantly.3
-
Report 3 · Study title
Interaction of fluvoxamine with warfarin in an elderly woman
An 80-year-old hospitalized woman was started on intravenous heparin and oral warfarin for an embolic stroke secondary to atrial fibrillation and mitral stenosis. Her warfarin dose was kept at 1 mg daily, with between 2.5 and 3.
FluvoxaMINE 25 mg daily was begun for depression, and 3 days later her warfarin dose was raised to 1.5 mg daily because of worsening left hemiparesis. Three days after that, her INR was 9.96, and a repeat INR to exclude laboratory error was 11.3.
Warfarin and fluvoxaMINE were discontinued, and fresh frozen plasma was given. Six days later, warfarin was restarted at 1 mg daily, and over 4 days the INR rose to 11.8.
The elevated INR was attributed to the persisting effect of fluvoxaMINE. She was eventually stabilized on warfarin 1 mg daily with INR values between 2 and 2.5.4
-
Report 4 · Study title
Prescribing information: Fluvoxamine maleate oral tablets, fluvoxamine maleate oral tablets
When fluvoxaMINE maleate (50 mg thrice daily) was given together with warfarin for two weeks, warfarin rose by 98% and prothrombin times were prolonged.1
Fluvoxamine and Edoxaban: Common Questions
How serious is the Fluvoxamine and Edoxaban interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Fluvoxamine and Edoxaban interaction managed?
Your care team can manage this combination with monitoring and individualized dosing. Keep taking both medicines exactly as prescribed unless your prescriber tells you otherwise. Expect your team to watch for signs of bleeding. Your dose may need to be adjusted and individualized by your care team. Report nosebleeds, unusual bruising, tiny red spots on the skin, blood in urine or sto… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "delayed". Effects tend to build up gradually over days to weeks.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Ask About the Fluvoxamine and Edoxaban Interaction
Ask in your own words about taking Fluvoxamine and Edoxaban together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (5)
- Product Information: Fluvoxamine maleate oral tablets, fluvoxamine maleate oral tablets. ANI Pharmaceuticals Inc (per FDA), Baudette, MN, 2023. DailyMed
- Wallerstedt SM, Gleerup H, Sundstrom A, et al: Risk of clinically relevant bleeding in warfarin-treated patients-influence of SSRI treatment. Pharmacoepidemiol Drug Saf 2009; 18(5):412-416. PubMed
- Schalekamp T, Klungel OH, Souverein PC, et al: Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins. Arch Intern Med 2008; 168(2):180-185. PubMed
- Yap KB & Low ST: Interaction of fluvoxamine with warfarin in an elderly woman. Singapore Med J 1999; 40:480-482.
- Product Information: LUVOX(R) CR extended-release oral capsules, fluvoxamine maleate extended-release oral capsules. Jazz Pharmaceuticals,Inc, Palo Alto, CA, 2008. DailyMed
Other Serious Interactions of Fluvoxamine and Edoxaban
Also serious with Fluvoxamine
- ColchicineContraindicated
- Linezolid InjectionContraindicated
- Metoclopramide InjectionContraindicated
- Metoclopramide Nasal SprayContraindicated
Also serious with Edoxaban
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Fluvoxamine
- Activated CharcoalMajor
- LithiumMajor
- CaffeineModerate
- Green TeaModerate
- Black PepperModerate
- GrapeModerate
- GinkgoModerate
- MelatoninModerate
- + 187 more
With Edoxaban
- Activated CharcoalMajor
- PiracetamMajor
- Vitamin EModerate
- SeleniumModerate
- GingerModerate
- TurmericModerate
- CaffeineModerate
- Green TeaModerate
- + 215 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven. This interaction.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks. This interaction.
- UnspecifiedThe timing of this interaction is not well characterized.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.